Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
DE000A161NR7
Wed, 20.08.2025
THE NAGA GROUP AG
Company Name:
THE NAGA GROUP AG
ISIN:
DE000A161NR7
Reason for the research:
Update
Recommendation:
BUY
from:
20.08.2025
Target price:
EUR 1.10
Target price on sight of:
12 months
Last rating change:
Analyst:
Frederik Jarchow
H1 EBITDA stands at € 3.0m (+8% yoy) and hence lower than anticipated (eNuW: € 4.0m), mainl [ … ]
Wed, 11.06.2025
THE NAGA GROUP AG
Company Name:
THE NAGA GROUP AG
ISIN:
DE000A161NR7
Reason for the research:
Update
Recommendation:
BUY
from:
11.06.2025
Target price:
EUR 1.20
Target price on sight of:
12 months
Last rating change:
Analyst:
Frederik Jarchow
Final FY24 above prelims // Solid Q1 figures; chg
Last week, NAGA reported final FY24 figures that came [ … ]
Tue, 11.02.2025
THE NAGA GROUP AG
Company Name:
THE NAGA GROUP AG
ISIN:
DE000A161NR7
Reason for the research:
Update
Recommendation:
Buy
from:
11.02.2025
Target price:
EUR 1.20
Target price on sight of:
12 months
Last rating change:
Analyst:
Frederik Jarchow
Mixed FY24 prelims // Detailed guidance for FY25&26; chg.
NAGA reported preliminary FY24 figures t [ … ]
Tue, 05.11.2024
THE NAGA GROUP AG
Company Name:
THE NAGA GROUP AG
ISIN:
DE000A161NR7
Reason for the research:
Update
Recommendation:
Buy
from:
05.11.2024
Target price:
EUR 1.40
Target price on sight of:
12 months
Last rating change:
Analyst:
Frederik Jarchow
Merger burdened H1 figures; Growth ahead; chg
Topic: Last week, NAGA reported unaudited figures for H1 [ … ]
Mon, 27.05.2024
THE NAGA GROUP AG
EGM approved merger with CAPEX chg est. & PT
Topic: During the recently held extraordinary general meeting, NAGA
received the approval for the merger with CAPEX with a 99.81% majority. As
the pending regulatory change of control process is rather a formality, we
adjust our estimates, now fully reflecting the merger with CAPEX. For FY24
we n [ … ]
Wed, 17.01.2024
THE NAGA GROUP AG
Strong FY23 prelims and merger with Capex.com; chg
Last week, NAGA reported preliminary FY23 figures that came stronger than
expected. Further, the company has announced (at the end of 2023) a planned
business combination with Capex.com. In detail:
- Sales came in at € 45.5m (-21% yoy), significantly above our estimates of
€ 38.1m. [ … ]
Mon, 20.11.2023
The NAGA Group AG
Strong earnings growth achieved in the first nine months of 2023, lower
sales growth but increase in profitability expected, price target: € 2.90,
rating: BUY
The NAGA Group AG recently published its annual report for the 2022
financial year, which is therefore late. The delayed publication is mainly
due to a change of auditor, the in [ … ]
Fri, 17.11.2023
THE NAGA GROUP AG
FY22 out // Short-term remains clouded; Restart with HOLD
Recently, NAGA finally reported its audited FY22 figures, which reflect a
particularly challenging year for the company. In detail:
Sales stand at € 57.6m (+9% yoy), above our estimates of € 50.1m, as we
have not considered NGC trading revenues of € 6.8m. While trading a [ … ]
Fri, 03.02.2023
The NAGA Group AG
First positive effects from initiated restructuring visible; Break-even
expected in the current financial year; Target price: € 3.60; Rating: BUY
Communication with the financial market of NAGA Group AG (NAGA for short)
in the past 2022 financial year was characterised by the postponement of
the 2021 annual report. Part of the delay wa [ … ]
Fri, 03.02.2023
The NAGA Group AG
First positive effects from initiated restructuring visible; Break-even
expected in the current financial year; Target price: € 3.60; Rating: BUY
Communication with the financial market of NAGA Group AG (NAGA for short)
in the past 2022 financial year was characterised by the postponement of
the 2021 annual report. Part of the delay wa [ … ]
